Transcriptomics

Dataset Information

0

Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity via XCR1+ Dendritic Cells

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus

PROVIDER: GSE126281 | GEO | 2019/02/13

REPOSITORIES: GEO

Json Xml

Similar Datasets

Genomics Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity via XCR1+ Dendritic Cells
| PRJNA521782 | ENA
Unknown Nanoparticulate Delivery of Cancer Cell Membrane Elicits Multiantigenic Antitumor Immunity.
| S-EPMC5794340 | biostudies-literature
Unknown Targeted Delivery of CXCL9 and OX40L by Mesenchymal Stem Cells Elicits Potent Antitumor Immunity.
| S-EPMC7704751 | biostudies-literature
Unknown Attraction and activation of dendritic cells at the site of tumor elicits potent antitumor immunity.
| S-EPMC2835257 | biostudies-literature
Unknown Targeting the intratumoral dendritic cells by the oncolytic adenoviral vaccine expressing RANTES elicits potent antitumor immunity.
| S-EPMC4146345 | biostudies-literature
Unknown Targeted antigen delivery to dendritic cells elicits robust antiviral T cell-mediated immunity in the liver.
| S-EPMC5339819 | biostudies-literature
Unknown In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
| S-EPMC8166607 | biostudies-literature
Unknown Adiponectin receptor signaling on dendritic cells blunts antitumor immunity.
| S-EPMC4314963 | biostudies-literature
Unknown Inhibition of SIRP? in dendritic cells potentiates potent antitumor immunity.
| S-EPMC5048764 | biostudies-literature
Metabolomics Nano-hijacked myeloid cells potentiate antitumor immunity and radiotherapy for glioblastoma
2023-02-06 | ST002467 | MetabolomicsWorkbench